Kevin Charles Gorman Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 18 hours ago
Kevin Charles Gorman has an estimated net worth of at least $111.5 million*, as of Feb. 12, 2025. They own 524,209 shares of NBIX stock. They have sold 390,358 shares of NBIX stock since 2021, for an estimated $51.2 million.
Kevin Charles Gorman $NBIX SEC Form 4 Insider Trading
Kevin Charles Gorman has filed a total of 21 insider trades in $NBIX since 2021. Their most recent trade was a sale of 3,012 shares, made on Feb 13, 2025. Their largest trade was a sale of 146,105 shares, made on Jan 27, 2025. We estimate that they now own 524,209 shares of $NBIX, worth an estimated $60.2 million.
Insider Trading at $NBIX
There have been a total of 320 insider trades reported at $NBIX since 2021, with 0 shares purchased and 1.9 million shares sold. The most active insider traders in $NBIX stock have been Julie Cooke, Eric Benevich, and Darin Lippoldt. The most recent trade was a sale of 755 shares reported by Julie Cooke (Chief Human Resources Officer), made on Feb 13, 2025.
History of Insider Stock Trades by Kevin Charles Gorman
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NBIX
|
Sale | 3,012 | Feb 13, 2025 | Feb. 14, 2025, 7:57 p.m. |
|
NBIX
|
Sale | 2,832 | Feb 13, 2025 | Feb. 14, 2025, 7:57 p.m. |
|
NBIX
|
Sale | 2,274 | Feb 10, 2025 | Feb. 12, 2025, 7:56 p.m. |
|
NBIX
|
Sale | 2,707 | Jan 31, 2025 | Feb. 4, 2025, 6:58 p.m. |
|
NBIX
|
Sale | 146,105 | Jan 27, 2025 | Jan. 29, 2025, 8:03 p.m. |
XNCR
|
Sale | 2,654 | Sep 27, 2024 | Oct. 1, 2024, 4:09 p.m. |
|
NBIX
|
Sale | 2,832 | Feb 13, 2024 | Feb. 15, 2024, 6:43 p.m. |
|
XNCR
|
Purchase | 53 | Feb 13, 2024 | Feb. 15, 2024, 5:02 p.m. |
|
NBIX
|
Sale | 3,040 | Feb 06, 2024 | Feb. 8, 2024, 8:21 p.m. |
|
NBIX
|
Sale | 2,274 | Feb 08, 2024 | Feb. 8, 2024, 8:21 p.m. |
|
NBIX
|
Sale | 2,707 | Jan 31, 2024 | Feb. 2, 2024, 8:21 p.m. |
|
NBIX
|
Sale | 105,835 | Jan 08, 2024 | Jan. 10, 2024, 5:31 p.m. |
|
NBIX
|
Sale | 62,023 | Jan 09, 2024 | Jan. 10, 2024, 5:31 p.m. |
|
NBIX
|
Sale | 9,328 | Aug 21, 2023 | Aug. 23, 2023, 8:08 p.m. |
|
NBIX
|
Sale | 2,274 | Feb 08, 2023 | Feb. 8, 2023, 8:28 p.m. |
|
NBIX
|
Sale | 3,040 | Feb 06, 2023 | Feb. 8, 2023, 8:28 p.m. |
|
NBIX
|
Sale | 3,248 | Feb 07, 2023 | Feb. 8, 2023, 8:28 p.m. |
|
NBIX
|
Sale | 20,482 | Feb 07, 2023 | Feb. 8, 2023, 8:28 p.m. |
|
NBIX
|
Sale | 2,707 | Jan 31, 2023 | Feb. 2, 2023, 6:19 p.m. |
|
NBIX
|
Sale | 2,422 | Feb 07, 2022 | Feb. 9, 2022, 8 p.m. |
|
NBIX
|
Sale | 3,040 | Feb 07, 2022 | Feb. 9, 2022, 8 p.m. |
|
NBIX
|
Sale | 2,274 | Feb 08, 2022 | Feb. 9, 2022, 8 p.m. |
|
NBIX
|
Sale | 3,248 | Feb 07, 2022 | Feb. 9, 2022, 8 p.m. |
$NBIX Executives and Stock Owners with Insider Trades
-
Julie Cooke, Chief Human Resources Officer
-
Eric Benevich, Chief Commercial Officer
-
Darin Lippoldt, Chief Legal Officer
-
Eiry Roberts, Chief Medical Officer
-
Ingrid Delaet, Chief Regulatory Officer
-
David W. Boyer, Chief Corp. Affairs Officer
-
Matt Abernethy, Chief Financial Officer
-
Kyle Gano, Chief Business Development Off
-
Kevin Charles Gorman, Chief Executive Officer
-
Jude Onyia, Chief Scientific Officer
-
Kyle Gano, Chief Executive Officer
-
Malcolm Lloyd-Smith, Chief Regulatory Officer
-
Malcolm Lloyd-Smith, Chief Integration Officer
-
Dimitri E. Grigoriadis, Chief Research Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.